22.12
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD require…
The pharmacological management of Peripheral Artery Disease includes cilostazol, which treats intermittent claudication by inhibiting platelet aggregation and promoting vasodilation.
Antiplatelet agents such as clopidogrel help prevent thromboembolism, while pentoxifylline reduces fibrinogen concentration, platelet adhesiveness, and blood viscosity.
Additionally, a supervised exercise program involving 30-45 minutes of walking or cycling three times a week and a low-calorie diet for overweight individuals focuses on sustained weight loss.
Interventional radiology procedures include percutaneous transluminal angioplasty, which uses a balloon-tipped catheter to enlarge blocked arteries, and the placement of stents to keep them open.
Atherectomy, including methods like laser atherectomy, uses ultraviolet energy to break down the atheroma.
Cryoplasty combines percutaneous transluminal angioplasty with cold therapy to reduce smooth muscle cell activity and minimize restenosis.
Surgical options include peripheral artery bypass, which redirects blood flow using an autogenous vein or synthetic graft, and endarterectomy, which removes obstructive plaque by opening the artery.
View the full transcript and gain access to JoVE Core videos
Q1: What medications are used to treat peripheral artery disease symptoms?
Cilostazol treats intermittent claudication by inhibiting platelet aggregation and promoting vasodilation. Antiplatelet agents like clopidogrel prevent thromboembolism, while pentoxifylline reduces fibrinogen concentration, platelet adhesiveness, and blood viscosity. ACE inhibitors such as ramipril help relax blood vessels and alleviate PAD symptoms.
Q2: How does supervised exercise therapy benefit patients with peripheral artery disease?
Supervised exercise programs involving 30 to 45 minutes of walking or cycling three times weekly for at least three months enhance walking ability and quality of life. Exercise therapy is highly recommended for intermittent claudication and helps improve overall cardiovascular function and limb perfusion in PAD patients.
Q3: What is percutaneous transluminal angioplasty and how does it work?
Percutaneous transluminal angioplasty uses a balloon-tipped catheter inserted through the femoral artery to compress atherosclerotic plaque and enlarge blocked arteries. After angioplasty, a metallic stent is placed to keep the artery open. Drug-coated balloons and stents reduce new tissue growth and improve long-term results.
Q4: How does cryoplasty differ from standard angioplasty in treating arterial blockages?
Cryoplasty combines percutaneous transluminal angioplasty with cold therapy using a balloon filled with liquid nitrous oxide that cools to 14°F (−10°C). This cold therapy reduces restenosis by limiting smooth muscle cell activity, offering improved long-term outcomes compared to standard angioplasty alone.
Q5: What surgical options are available for peripheral artery disease?
Peripheral artery bypass surgery redirects blood flow using an autogenous vein or synthetic graft to bypass blocked arteries. Endarterectomy removes obstructive plaque by opening the artery. Patch graft angioplasty involves removing plaque and widening the lumen with a patch to restore adequate blood flow.
Q6: Why is tobacco cessation critical in managing peripheral artery disease?
Tobacco cessation is crucial because smoking damages blood vessels, reduces oxygen in the blood, increases blood pressure, and promotes plaque buildup in arteries. Quitting smoking improves heart health, reduces the risk of heart attacks and strokes, and enhances overall cardiovascular function in PAD patients.
Q7: What role does atherectomy play in interventional treatment of PAD?
Atherectomy removes obstructing plaque using various methods including directional atherectomy with a high-speed cutting disk, laser atherectomy using ultraviolet energy to break down atheroma, and diamond-coated tip devices. These catheter-based procedures offer alternatives to surgery for treating lower extremity PAD.